Most Popular Angioplasty Web Site
Expert Insights & Feature Articles
Medtronic Begins Trial for Next-Generation Drug-Eluting Stent in Small Arteries
Medtronic Resolute Onyx stent picture on map of U.S.
Medtronic is beginning the U.S. pivotal trial for its new drug-eluting stent, the Resolute Onyx™. The Onyx received the European CE Mark in November and has been available in countries that recognize the CE Mark. The first phase of this trial will be studying one of the most challenging clinical scenarios: blockages in arteries that measure as small as 2.0mm.
Consumer Reports Overstates Cardiac CT Radiation Dose
Cardiac CT 3D image
Consumer Reports regularly publishes health information to aid the consumer/patient in making decisions. That's good, but also important is having the most current information, which their recent article about CT scans does not. The article states that a Cardiac CT Angiogram (CTA) exposes the patient to 12 mSv of ionizing radiation, or 120 times that of a chest X-ray. This was true years ago, when CTA was first being used to diagnose coronary artery disease. But it is not true today.
Medtronic Launches Drug-Coated Balloon for Peripheral Artery Disease in U.S.
Maintenance of Certification exam and OR
The IN.PACT Admiral is the second such device approved by the FDA, the first being Bard's Lutonix back in October. The approval was supported by a body of clinical evidence of 21 studies involving more than 3,500 patients worldwide, demonstrating the best clinical outcomes of any medical technology for the treatment of PAD in the SFA and popliteal arteries.
Who's Sorry Now? The ABIM, That's Who
Upper leg arteries (superfiical femoral and popliteal)
The American Board of Internal Medicine (ABIM) has apologized to the medical community saying they "had gotten it wrong." What the ABIM had gotten "wrong" was the Maintenance of Certification (MOC) changes passed a year ago. Many physicians had objected to what they felt were onerous, time-consuming, worthless and expensive requirements.
Philips Buys Volcano: It's About Money, Technology, and History
Volcano and Philips logos
The acquisition of Volcano by Philips is a landmark event in the world of imaging. For years, Volcano's mantra was "angiography alone is not enough." Well now, angiography agrees and one of the largest manufacturers of cath labs will be offering IVUS, FFR and iFR modalities as part of its total imaging package. The potential spread of these technologies can only benefit patients, with better outcomes and more targeted procedures, and also save hospitals and healthcare systems money.
FDA Approves HeartFlow FFR-CT: Non-Invasive Method for Determining Coronary Ischemia
HeartFlow FFR-CT 3D Analysis
The FDA has approved HeartFlow's FFR-CT software for measuring coronary blockages non-invasively. While the accuracy of FFR-CT to correctly differentiate significant blockages from those not needing revascularization is only in the mid-80% range, the fact that a CT scan can be performed quickly, non-invasively, and with relatively low radiation doses, makes this procedure a significant contender to the extremely common nuclear stress test, and a potential game-changer in the diagnosis of coronary artery disease.
DAPT Study: Extended Treatment After Stenting Lowers Stent Thrombosis and Heart Attacks
Road map with traffic
"Longer is better." That's what Dr. Dean Kereiakis told Angioplasty.Org when characterizing the results of the long-awaited Dual Antiplatelet Therapy (DAPT) study, which were presented today at the annual American Heart Association Scientific Sessions in Chicago. Dr. Kereiakes is the co-principal investigator for this five year study of 10,000 patients, which adds to the knowledge base of whether long-term treatment with aspirin and a thienopyridine, such as Plavix, after stent implantation is beneficial to patients.
Fractional Flow Reserve: Measuring Pressures in the Marketplace
Dr. Andreas Gruentzig in cath lab
The FFR market has been a duopoly, split almost evenly between St. Jude Medical and Volcano Corporation. While these companies compete with each other, both have expressed upon occasion that the real challenge to increasing their sales and profits is not in gaining share from each other, but from expanding the field of FFR as a whole. However, some new smaller device companies are beginning to enter the marketplace. And the technology is slightly different: instead of pressure wires, these newer systems are utilizing fiber-optics.
FFR and iFR: Roadmapping Your Heart, With Traffic
Road map with traffic
What has become clearer in the past few years is that seeing is not believing. The angiogram may show a narrowing, but that narrowing may not be causing a reduced flow of blood to the heart, a.k.a. "ischemia." Stenting or bypassing such a "non-ischemic" narrowing may not be of much benefit to the patient, but it will add a small risk factor of stent restenosis or perhaps a surgical complication.
ZEUS: Drug-Eluting Stent Outperforms Bare Metal for Safety and Efficacy in At-Risk Patients
The ZEUS trial of 1,606 patients showed that the use of Medtronic's Endeavor zotarolimus-eluting stent is associated with a lower risk of major cardiac events at one year compared to bare metal stents among a patient population normally excluded from treatment with drug-eluting stents.
FDA Approves Volcano's iFR® Pressure Measurement Modality for Use in Coronary Stent Guidance
Volcano's iFR system measures intracoronary pressures without need for adenosine
The FDA has granted approval to Volcano's proprietary coronary pressure measurement modality, iFR (Instant wave-Free Ratio). iFR represents a significant advance in the field of functional measurement (FM), in which the actual flow pressures inside the coronary artery can be measured and the deficit caused by a coronary blockage or lesion can be accurately assessed.
Wrist Angioplasty Sees Unprecedented Growth in U.S.
Radial growth in the U.S.
In the current issue of Circulation, a landmark analysis of almost 3 million coronary interventions performed in the U.S. from 2007 to 2012 concludes that utilization of the transradial approach, in which balloons and stents are delivered to the heart via the radial artery in the wrist instead of the femoral artery in the groin, has increased 13-fold in the past five years.
Interventional Cardiologist Dr. Sanjay Patel
"The Whole Story is About Increasing Patient Happiness."
Interview with Dr. Ferdinand Kiemeneij
In this two-part 20th anniversary interview, the "father of transradial intervention, " talks about the history and future of TRI.
Interventional Cardiologist Dr.Ron Caputo
"Transradial Has Gone From a Physician-Centered to an Institutional Concern."
Interview with Dr. Ron Caputo
The landscape of transradial has changed in the past 5 years from introductory "evangelical" didactic lectures to mentorship and adoption by hospitals for economic benefit and improved patient care..

Angioplasty News

RSS Angioplasty News Feed Get our RSS News Feed
ACC Reacts to CMS' Proposed Rule for Meaningful Use Stage 3 (Mar 20)
SCCT Statement on the PROMISE Clinical Trial (Mar 14)
Medtronic Begins Testing a "Drug-Filled Stent" (Mar 14)
Medtronic Begins Trial for Next-Generation Drug-Eluting Stent in Small Arteries (Mar 12)
Consumer Reports Overstates Cardiac CT Radiation Dose (Mar 11)
SCCT Names Norm Linsky New Executive Director (Feb 27)
Medicare Approves Drug-Coated Balloons for Outpatient Leg Angioplasty (Feb 26)
Philips Acquisition of Volcano Completed (Feb 17)
Medtronic Gets CE Mark for Euphora Semicompliant Balloon (Feb 16)
Clinton and Eisenhower: Presidents, Hearts, Stents and 55 Years (Feb 15)
Svelte & ASAHI to Collaborate on Fixed Wire Stent System (Feb 15)
AHA-ASA & Medtronic Collaborate to Reduce Recurrent Strokes (Feb 13)
Medtronic ICMs Detect Atrial Fibrillation in Stroke Patients in 'Real-World' Study (Feb 11)
Boston Scientific to Distribute Bard's Lutonix Drug-Coated Balloon for Blockages in Leg Arteries (Feb 10)
The NBPAS Expands Certification Program (Feb 6)
Medtronic Launches Drug-Coated Balloon for PAD in U.S. (Feb 5)
Philips Extends Tender Offer Period to Feb 17 to Acquire Volcano (Feb 5)
Medtronic Gets CE Mark for Larger Sizes of CoreValve (Feb 5)
Who's Sorry Now? The ABIM, That's Who (Feb 4)
ABIM Announces Immediate Changes to MOC Program (Feb 3)
CoreValve: Survival & Safety Benefit Compared to Open Surgery for Patients with Prior CABG (Jan 28)
FDA Approves Melody Transcatheter Pulmonary Valve (Jan 27)
Medtronic Completes Acquisition of Covidien (Jan 26)
Dr. Rob Califf named FDA Deputy Commissioner (Jan 26)
Opsens Fiber Optic System Utilized by FFR Pioneers in Europe and Japan (Jan 21)
The National Board of Physicians and Surgeons Launches (Jan 15)
New MOC Requirements: Scalpel… Suture… Suction… Pencil? (Jan 8)
New Treatment for Peripheral Artery Disease Approved by the FDA (Jan 6)
FDA Approves Medtronic's IN.PACT Drug-Coated Balloon for PAD (Jan 6)
Circulation: Medtronic DCB Tops PTA for peripheral artyer disease (Dec 22)
Philips Buys Volcano: It's About Money, Technology & History (Dec 19)
Philips to Acquire Volcano for $1.2 Billion (Dec 17)
Volcano: 1,000 iFR Systems in Use Worldwide (Dec 16)
Excellent Long-Term Outcomes for EVAR with Medtronic's Endurant AAA Stent Graft (Dec 9)
From Bench to Bedside to Bench Revisited: Supreme Court Justice Ginsburg Back in Action (Dec 1)
Supreme Court Justice Ginsburg Released from Hospital 1 Day After Receiving Stent (Nov 27)
Medtronic Acquisition of Covidien Gets FTC Clearance (Nov 26)
FDA Approves HeartFlow FFR-CT: Non-Invasive Method for Determining Coronary Ischemia (Nov 26)
1 Year Data from EVOLVE II Trial Shows Safety & Efficacy for Boston Scientific's SYNERGY Bioabsorbable Polymer Stent (Nov 21)
Encouraging Results for Lombard's Aorfix AAA Stent Graft (Nov 20)
The Beginnings of EVAR Endovascular AAAA Repair (Nov 18)
DAPT Study: Extended Treatment After Stenting Lowers Stent Thrombosis & Heart Attacks (Nov 16)
Plavix and Aspirin After Stent: 8 Years Later – Is Longer Better? (Nov 16)
New AAA Stent Graft Approval for Medtronic (Nov 14)
Medtronic Sponsors American Diabetes Association Educational Campaign for 2nd Year (Nov 14)
Vascular Surgery and the Battlefield: Honoring Our Veterans (Nov 11)
Fractional Flow Reserve: Measuring Pressures in the Marketplace (Nov 6)
Crazy Charlie's Amazing Idea: Angioplasty at 50 (Nov 5)
5-Year Data for Zilver PTX Drug-Eluting Stent for Leg Arteries Show Continued Efficacy (Nov 4)
IN.PACT Drug-Coated Balloon Shows Safety & Efficacy for Peripheral Angioplasty in Diabetics (Nov 4)
VIVA 2014 Starts in Las Vegas - Looking Back at the 1st EVAR (Nov 3)
Medtronic's New Onyx Drug-Eluting Stent Gains CE Mark (Nov 3)
Opsens Files To Become a New Player in FFR Market (Oct 20)
Boston Sci Begins Study of DES in Women and Minorities (Oct 20)
FFR and Ebola: Thresholds and Decision-Making (Oct 16)
FDA OK to Medtronic's MRI-Safe Pacing Lead (Oct 14)
Positive 30-Day Results in CoreValve Direct Aortic Study (Oct 13)
FDA Approves Lutonix: 1st Drug-Coated Balloon for PAD (Oct 12)
ACIST Showcases Hi-Definition IVUS System (Oct 8)
Will a Denial of Service DOS Attack Hit NYS Medicaid Patients? (Oct 5)
FFR and iFR: Roadmapping Your Heart, With Traffic (Oct 3)
Japanese Approval for Infraredx NIR/IVUS Imaging System (Sep 30)
Engaged Sends a Letter to Volcano Corporation, and Volcano Replies (updated Sept 30)
Medtronic DCB Shows Strong Clinical & Economic Benefit (Sep 16)
FDA OKs Medtronic's Euphora Non-Compliant Balloon (Sep 11)
Medtronic Begins U.S. Trial of Recapturable CoreValve (Sep 10)
Visit current news, and news archives

Selected as a top resource on Stents
by the Editors of

NY Times Stent Resource
Burt Cohen, Editor of Angioplasty.Org
"Voice in the Ear": Editor Burt Cohen's stent and device blog.

Recent Posts:

The Activated Patient
"The Activated Patient": Patient info and empowerment blog
Patients Are Talking About...
  • I had radial angiography 2 days was a fascinating experience and was able to watch part of the procedure. I feel fantastic, have no "heart ache" or any problems with my arm.
  • I can't afford my post-stenting meds, where can I find help paying for Plavix or Effient?
  • I'm 64. After 4 stents and 2 heart attacks since Dec. 2008, I'm as physically active or more so than ever. I plan to hit 4,000 miles on my bike this year. I've hiked/climbed at 13,000 feet.
Patients Are Reading About...
Plavix and Stent
Patient Alert!: How to Get the Best Price on New Generic Plavix
Our survey found prices from 35¢ to $6 per pill. Read on for more resources to help you get the most affordable antiplatelet drugs, plus a look at the role of online patient communities.
5 Crucial Questions To Ask Your Doctor About New Heart Disease Treatments
Make sure you are benefiting from the most up-to-date research, and have access to the treatments that best fit your needs and preferences.
   Doctor and Patient
Radial Hospital Locator
A list of physicians and hospitals offering the transradial (wrist) approach to angiograms, angioplasty and stent procedures.
  Transradial Hospital
Read patient stories and Learn about medications after stenting, symptoms and complications, care giving, taking charge of your health, communicating with your cardiologist and much more in our Patient Center.
Angioplasty Inventor, Dr. Andreas Gruentzig
see video clip:
" The 1st Angioplasty"
ANGIOPLASTY AT 35: 2012 marked the 35th anniversary of coronary angioplasty. In 1977 in Zurich, Switzerland, a young physician named Andreas Gruentzig inserted a catheter into a patient's coronary artery and inflated a tiny balloon, successfully opening a blockage and restoring blood flow to a human heart.
Today over two million coronary angioplasties are performed worldwide each year and angioplasty has become the gold standard for emergency heart attack treament.
(View videos, interviews, and photos in our Angioplasty History Center, or order our DVD, "PTCA: A History.") Angioplasty History DVD
What People Are Saying About Angioplasty.Org:
"Everyone, please consider donating to this site, it is a wealth of information and comfort. Where else can you get such great information AND expedited? My dr's don't return phone calls as quickly as I've gotten responses here!" -- Denise, Connecticut, USA
"Angioplasty.Org is awesome; I always refer patients to it. It makes a difference big time. They go and they look and see all the people interviewed and these well-known cardiologists around the world talking about it, and it takes that anxiety away." -- Sanjay Patel, MD, Houston, Texas, USA
"Thanks to Angioplasty.Org for all the info which helped a lot in my decision making and post procedure recovery." -- Muralidharan, Chennai, India
"Burt Cohen (Senior Editor of Angioplasty.Org) has been documentarian of this field of medicine for 30 years" -- Dr. Stephen Oesterle, SVP Medicine and Technology, Medtronic Corp.
"I just want you to know that you probably saved [my husband's] life by telling your story, and I want to thank you for it." -- Marie, Canada
Like your local educational TV or radio station, Angioplasty.Org relies on help from visitors like you. The grant funding we receive does not fully cover our costs; please consider making a recurring monthly contribution or a one-time donation.
Thank You to Our Industry Grantmakers:
Medtronic, Inc.
Volcano Corporation
Toshiba America
Medical Systems
Cardium Therapeutics
Lenox Hill Heart and Vascular Institute of NY
Freddie Award for International Health and Medical Media
Britannica Selection
Selected as an "Internet iGuide" by Encyclopedia Brittanica
    Health On the Net

send comments & suggestions to "info at angioplasty dot org"
Read our Privacy statement.

Angioplasty.Org is an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY

For more information, see About Us
All content, including text, photos and video
© Copyright Venture Digital LLC 1996-2015